Boston An independent LDT provider
NOTE:Immunovia has ceased commercialization of the IMMray PanCan-d test. More information available here: https://rb.gy/09bxx

Press releases

May 18, 2016

Inbjudan till Immunovia Informationsmöte i Stockholm den 1 juni kl 17.30 med VD MatsGrahn och Styrelseordförande Carl Borrebaeck

Read press release
May 9, 2016

IMMUNOVIA JOINS MORE THAN 40 GLOBAL PANCREATIC CANCER ORGANIZATIONS AT INAGURAL MEETING

Read press release
April 26, 2016 | REGULATORY

Immunovia kallar till årsstämma 2016

Read press release
April 8, 2016 | REGULATORY

Immunovia appoints Dr. Marco Del Chiaro from Karolinska Institute to Scientific Advisory Board

Read press release
April 1, 2016

NOTE about Immunovia and IMMray™ technology information on newswires and social media

Read press release
March 9, 2016 | REGULATORY

Immunovia partners with leading healthcare consultingservices firm

Read press release
March 8, 2016

Immunovia launches Swedish website

Read press release
February 29, 2016 | REGULATORY

Immunovia starts collaboration with multinational life science company on new systemic lupus erythematosus (SLE) diagnostics test

Read press release
February 24, 2016 | REGULATORY

Immunovia Year-end report 2015

Read press release
February 10, 2016 | REGULATORY

Immunovia and Lund University start clinical validation studies of Systemic Lupus Erythematosus (SLE) biomarker signatures

Read press release
February 9, 2016 | REGULATORY

Immunovia announces collaboration with Mount Sinai Health System to validate early detection blood test for pancreatic cancer

Read press release
January 19, 2016 | REGULATORY

Immunovia and the University of Liverpool enter into a collaboration in a prospective clinical study

Read press release
1 25 26 27 28